A multicenter, open-label, phase I/II study in patients with unresectable stage III non-small cell lung cancer (NSCLC) treated with L-BLP25: 2-year survival and safety results Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Murray, NR
  • Butts, C
  • Smith, C
  • Ellis, Peter
  • Jasas, K
  • Maksymiuk, A
  • Goss, G
  • Ely, G
  • Soulieres, D

publication date

  • May 20, 2008